Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesoblast (MESO) Operating Expenses (2016 - 2023)

Historic Operating Expenses for Mesoblast (MESO) over the last 9 years, with Q2 2023 value amounting to -$2.6 billion.

  • Mesoblast's Operating Expenses rose 75.23% to -$2.6 billion in Q2 2023 from the same period last year, while for Dec 2024 it was -$2.6 billion, marking a year-over-year decrease of 21153.61%. This contributed to the annual value of $74.1 million for FY2025, which is 1456.04% up from last year.
  • Per Mesoblast's latest filing, its Operating Expenses stood at -$2.6 billion for Q2 2023, which was up 75.23% from $1.0 billion recorded in Q1 2023.
  • Over the past 5 years, Mesoblast's Operating Expenses peaked at $1.6 billion during Q1 2021, and registered a low of -$6.6 billion during Q2 2021.
  • Over the past 5 years, Mesoblast's median Operating Expenses value was $479.5 million (recorded in 2019), while the average stood at -$297.2 million.
  • As far as peak fluctuations go, Mesoblast's Operating Expenses crashed by 1699201.57% in 2020, and later soared by 569810.37% in 2021.
  • Over the past 5 years, Mesoblast's Operating Expenses (Quarter) stood at $650.5 million in 2019, then tumbled by 102.19% to -$14.2 million in 2020, then soared by 5698.1% to $797.1 million in 2021, then fell by 6.61% to $744.4 million in 2022, then tumbled by 454.5% to -$2.6 billion in 2023.
  • Its Operating Expenses was -$2.6 billion in Q2 2023, compared to $1.0 billion in Q1 2023 and $744.4 million in Q4 2022.